Harrow Health (HROW) Misses Q3 EPS by 7c

Harrow Health (NASDAQ: HROW) reported Q3 EPS of ($0.12), $0.07 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $34.3 million versus the consensus estimate of $52.8 million.

For earnings history and earnings-related data on Harrow Health (HROW) click here.

You May Also Be Interested In

• UBS says bull market has further to run
• S&P 500 may pull back before midterms, but Citi says buy the dip
• Redwood Trust (RWT) PT Lowered to $6.50 at UBS Amid Legacy Portfolio Wind-Down